The first research results have been submitted to and published in scientific, peer-reviewed journals. 

• Beran, K., Hermans, E., Holm, R., Sepassi, K., Dressman J. (2023). Projection of Target Drug Particle Size in Oral Formulations Using the Refined Developability Classification System (rDCS). Pharmaceutics. https://doi.org/10.3390/pharmaceutics15071909
• Holzem, F. L., Jensen, I. H., Schaffland, J. P., Stillhart, C., Brandl, M., & Bauer-Brandl, A. (2023). Combining in vitro dissolution/permeation with microdialysis sampling: Capabilities and limitations for biopharmaceutical assessments of supersaturating drug formulations. European Journal of Pharmaceutical Sciences, 106533. https://doi.org/10.1016/j.ejps.2023.106533
• Panbachi, S., Beranek, J., & Kuentz, M. (2023). Polymer-embedded deep eutectic solvents (PEDES) as a novel bio-enabling formulation approach. European Journal of Pharmaceutical Sciences, 106463. https://doi.org/10.1016/j.ejps.2023.106463
• Guidetti, M., Hilfiker, R., Kuentz, M., Bauer-Brandl, A., & Blatter, F. (2022). Exploring the Cocrystal Landscape of Posaconazole by Combining High-Throughput Screening Experimentation with Computational Chemistry. Crystal Growth & Design. https://doi.org/10.1021/acs.cgd.2c01072
• Holzem, F. L., Weck, A., Schaffland, J. P., Stillhart, C., Klein, S., Bauer-Brandl, A., & Brandl, M. (2022). Biopredictive capability assessment of two dissolution/permeation assays, µFLUX™ and PermeaLoop™, using supersaturating formulations of Posaconazole. European Journal of Pharmaceutical Sciences, 176, 106260. https://doi.org/10.1016/j.ejps.2022.106260
• Holzem, F. L., Schaffland, J. P., Brandl, M., Bauer-Brandl, A., & Stillhart, C. (2022). Microdialysis and nanofiltration allow to distinguish molecularly dissolved from colloid-associated drug concentrations during biomimetic dissolution testing of supersaturating formulations. European Journal of Pharmaceutical Sciences, 174, 106166. DOI: 10.1016/j.ejps.2022.106166